Acarix

Our executive team recently visited our production facility in Denmark to evaluate opportunities for enhancing efficiency and scalability of our #MedicalDevice. With growing demand for our innovative CADScor System, we're proactively optimizing our production processes to meet future needs. We're excited to scale our production and bring our innovative #MedTech to more #healthcare professionals and patients worldwide.

Our CEO Aamir Mahmood recently spoke at Redeye AB's Cardiovascular and Metabolic Diseases event about our first-in-class CADScor System, and how we're working to transform early cardiac diagnostics with accessible, non-invasive solutions. As we expand, especially in the U.S. market, we're excited about the potential impact of our #MedTech on global cardiac health. Watch the full presentation here: https://lnkd.in/gsQ2f2DG

Check out our CEO Aamir Mahmood live at the Redeye AB Cardiovascular and Metabolic Diseases event. Join the livestream here: https://lnkd.in/dgfZAGrP

Happening tomorrow Oct 17th! Excited to be part of the Redeye AB Cardiovascular and Metabolic Diseases event to discuss the Acarix CADScor System. Join me live at 9:30 a.m. (CET) to explore how Acarix is revolutionizing early cardiac diagnostics with our innovative CADScor System. https://lnkd.in/gv_GWbrC Don't miss this opportunity to learn more about Acarix and the impact of our CADScor System on cardiac health. #acarix #coronaryarterydisease #CAD #ruleoutCAD #pointofcare

Significant results from the FILTER-SCAD trial were unveiled at the European Society of Cardiology and published in the European Heart Journal, marking a turning point in coronary artery disease (CAD) diagnostics. These findings affirm the CADScor System's potential to streamline diagnostic processes and cut healthcare costs. Key Insights: – Increased Patient Reassurance – Streamlined Diagnostic Processes – Significant Cost Savings for Healthcare Systems Dr. Chrysant's expert insights further confirm a promising future in cardiac care, with the CADScor System setting new standards in the field. Learn more about how this groundbreaking trial is shaping the future of healthcare: https://lnkd.in/gjs7xpEJ #Cardiology #MedicalDevices #HealthcareInnovation

Watch Prof. Andreas Götte share his experience with the CADScor System in his busy practice in Paderborn, Germany. #Acarix #CADScorSystem #CADScor #coronaryarterydisease #CAD #riskstratification #cardiology https://lnkd.in/gHwdAqwP

The CADScor System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. The system calculates a patient-specific CAD-score, and couples it with risk factors to rapidly indicate the patient’s risk of significant coronary stenosis for immediate risk stratification, prior to potential secondary evaluation. Learn more: https://lnkd.in/e-M8PtE2 #Acarix #CADScor #CADScorSystem #coronaryarterydisease #CAD #pointofcare #riskstratification #cardiology #ED #urgentcare

Today, Acarix reported its financial results for the second quarter of 2024. The company achieved record-breaking patch sales and record-breaking gross profit, driven by the success of its new sales model coupled with key strategic initiatives involving commercial expansion and clinical activities. These results highlight the company's growing market presence and commitment to innovation in the cardiac diagnostics space. Click here for additional details: https://lnkd.in/gfc49Jtc #Acarix #CADScor #CADScorSystem #CAD #coronaryarterydisease #pointofcare #riskstratification #Q2results #Q2earnings Aamir Mahmood

Acarix will publish its second-quarter results on Thursday, August 22, 2024, at 08.00 am (CET). Additionally, President and CEO Aamir Mahmood will present the report during a live webcast at 14.00 pm (CET) on the same day. Click here for details: https://lnkd.in/gYSuhecr #Acarix #CADScor #CADScorSystem #CAD #coronaryarterydisease #pointofcare #quarterlyresults

Visit the Acarix website to schedule a demo of the CADScor®System https://lnkd.in/gGUfE8Qs #Acarix #CADScor #CADScorSystem #CAD #coronaryarterydisease #pointofcare #ED #primarycare #cardiology